We are live on ! Find out more
TTPH

Tetraphase Pharmaceuticals, Inc.
TTPH

Delisted

TTPH was delisted on the 28th of July, 2020.

Back to rankings

89 hedge funds and large institutions have $170M invested in Tetraphase Pharmaceuticals, Inc. in 2017 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 32 increasing their positions, 23 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

218% more call options, than puts

Call options by funds: $1.71M | Put options by funds: $537K

134% more capital invested

Capital invested by funds: $72.6M → $170M (+$97.4M)

39% more repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 23

14% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 14

2% less funds holding

Funds holding: 91 → 89 (-2)

Holders
89
Holders Change
-2
Holders Change %
-2.2%
% of All Funds
2.22%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
32
Reduced
23
Closed
14
Calls
$1.71M
Puts
$537K
Net Calls
+$1.17M
Net Calls Change
+$1.15M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$12.9M
2
TCM
Tekla Capital Management
Massachusetts
+$4.55M
3
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$2.29M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$1.29M
5
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$1.22M

Top Sellers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
-$4.68M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$3.31M
3
Renaissance Technologies
Renaissance Technologies
New York
-$1.18M
4
CS
Candriam SCA
Luxembourg
-$970K
5
NI
Numeric Investors
Massachusetts
-$725K
Name Holding Trade Value Shares
Change 		Change in
Stake
BlackRock
1
BlackRock
New York
$21.1M +$12.9M +114,654 +30,093%
Canada Pension Plan Investment Board
2
Canada Pension Plan Investment Board
Ontario, Canada
$15.2M – – –
Vanguard Group
3
Vanguard Group
Pennsylvania
$15.1M +$1.29M +11,521 +16%
Wellington Management Group
4
Wellington Management Group
Massachusetts
$13.7M -$4.68M -41,748 -36%
Fidelity Investments
5
Fidelity Investments
Massachusetts
$12.7M -$3.31M -29,555 -30%
TCM
6
Tekla Capital Management
Massachusetts
$9.23M +$4.55M +40,600 +422%
Northern Trust
7
Northern Trust
Illinois
$7.78M +$66.4K +592 +1%
RSCM
8
Rock Springs Capital Management
Maryland
$6.42M – – –
State Street
9
State Street
Massachusetts
$6.26M -$165K -1,472 -4%
Dimensional Fund Advisors
10
Dimensional Fund Advisors
Texas
$5.83M +$2.29M +20,404 +180%
EAM
11
Eventide Asset Management
Massachusetts
$5.51M – – –
Acadian Asset Management
12
Acadian Asset Management
Massachusetts
$3.48M +$1.1M +9,851 +108%
Morgan Stanley
13
Morgan Stanley
New York
$2.92M +$941K +8,396 +112%
Geode Capital Management
14
Geode Capital Management
Massachusetts
$2.88M +$255K +2,278 +17%
Millennium Management
15
Millennium Management
New York
$2.84M +$848K +7,569 +96%
RPAM
16
Rhenman & Partners Asset Management
Sweden
$2.76M – – –
California Public Employees Retirement System
17
California Public Employees Retirement System
California
$2.18M +$71.2K +635 +6%
Balyasny Asset Management
18
Balyasny Asset Management
Illinois
$2M +$1.22M +10,875 New
CS
19
Candriam SCA
Luxembourg
$1.85M -$970K -8,650 -46%
Bank of New York Mellon
20
Bank of New York Mellon
New York
$1.73M +$34.3K +306 +3%
Deutsche Bank
21
Deutsche Bank
Germany
$1.65M -$441K -3,936 -30%
Federated Hermes
22
Federated Hermes
Pennsylvania
$1.52M +$193K +1,720 +26%
TCIM
23
TIAA CREF Investment Management
New York
$1.49M +$193K +1,725 +27%
PP
24
PDT Partners
New York
$1.45M +$882K +7,864 New
BCM
25
Bridgeway Capital Management
Texas
$1.42M -$707K -6,305 -45%
1
2 3 4 5

TTPH Hedge Fund Activity: Q1 2017 in Review

89 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Tetraphase Pharmaceuticals, Inc. (TTPH) for Q1 2017, worth a combined $170M — up 134% from $72.6M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new TTPH positions and 14 closed out — a net gain of 2 holders — while 32 added to existing stakes and 23 trimmed.

The largest buyer was BlackRock, adding an estimated $12.9M. The largest seller was Wellington Management Group, cutting an estimated $4.68M.

  • 89 institutional investors held Tetraphase Pharmaceuticals, Inc. (TTPH) as of Q1 2017, down from 91 in Q4 2016.
  • Funds reported $170M of Tetraphase Pharmaceuticals, Inc. stock for Q1 2017, up 134% quarter-over-quarter.
  • 16 funds opened new Tetraphase Pharmaceuticals, Inc. positions in Q1 2017 and 14 closed out, a net change of +2 holders.
  • The largest Tetraphase Pharmaceuticals, Inc. buyer in Q1 2017 was BlackRock, an estimated $12.9M added.
  • The largest Tetraphase Pharmaceuticals, Inc. seller in Q1 2017 was Wellington Management Group, an estimated $4.68M sold.

Based on aggregated 13F filings for Q1 2017.